CAHNeutral (ASignal Rank 3/4)

ASignal's 10+ AI agent pipeline rates CAH as Neutral with 88% confidence in the Healthcare sector.

AI Analysis Summary

Cardinal Health (CAH) presents a mixed investment profile with conflicting signals between growth potential and structural risks. While strong free cash flow and market position offer appeal, weak liquidity, negative book value, and a bearish forecast create uncertainty.

Investment Framework Assessment

Evaluated through three legendary investor frameworks:

  • Warren Buffett (Value Investing): Grade C — 55/100
  • Bill Ackman (Activist Investing): Grade B — 66/100
  • Ray Dalio (Macro/Risk Parity): Grade D — 42/100

Consensus: Neutral

Price Intelligence

  • Current price: $205.62
  • Price target: $204.09 (-0.7%)
  • Risk level: high
  • Horizon: medium term

Quality Assessment

  • Balance sheet: concerning
  • Cash flow: excellent
  • Competitive moat: efficient scale

Peer Group Analysis

CAH is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.

CAH Neutral Signal — AI Analysis | ASignal